Executive Director, Global HIV Public Affairs at Gilead Sciences

Foster City, California, United States

Apply Now

Not SpecifiedCompensation

Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Dynamic and strategic leadership experience in communications and advocacy
Expertise in HIV therapeutic area or related biopharmaceutical field
Ability to develop and execute integrated communications and advocacy strategies
Strong collaboration skills with cross-functional teams (e.g., Global Commercial Product Strategy & Operations, Clinical Development, Medical Affairs, Government Affairs)
Capability to articulate vision across external and internal audiences
Experience raising awareness of unmet medical needs and communicating progress

Responsibilities

Develop and execute an integrated communications and advocacy strategy for Global HIV Public Affairs
Advance Gilead’s position as a leader in HIV treatment and prevention
Articulate Gilead’s vision in the HIV therapeutic area to external and internal audiences
Raise awareness of unmet medical needs addressed by Gilead’s science and programs
Communicate progress against strategic goals in HIV
Work closely with therapeutic area leads in Global Commercial Product Strategy & Operations, Clinical Development, Medical Affairs, and Government Affairs
Engage collaboratively across functions to support Gilead’s mission in HIV

Skills

Public Affairs

HIV Policy

Stakeholder Engagement

Strategic Communications

Government Relations

Global Health Advocacy

Leadership

Policy Development

Advocacy

Team Management

Gilead Sciences

Develops and commercializes biopharmaceuticals

About Gilead Sciences

Gilead Sciences focuses on discovering, developing, and commercializing medicines for various medical conditions, including HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular issues. The company conducts extensive research and development to create new therapies, which are then marketed to healthcare providers, hospitals, and pharmacies after receiving regulatory approval. Gilead differentiates itself from competitors through its strong commitment to R&D and strategic partnerships, such as with SAP Ariba, to enhance its operations and product offerings. The company's goal is to improve health equity and access to care globally, working with communities to ensure that its medicines reach those in need.

Foster City, CaliforniaHeadquarters

1987Year Founded

$15,873.6MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Paid family time off and paid parental time off

Generous 401(k) contribution matching

Comprehensive medical plans that cover both physical and mental healthcare

Global Wellbeing Reimbursement

Time Off

Global Volunteer Day

Giving Together Program

Employee Support Programs

Flexible Work Options

Risks

Increased competition in HIV treatment from ViiV Healthcare's expanding drug portfolio.

Regulatory scrutiny over drug pricing could impact Gilead's U.S. market operations.

Patent expirations, like Truvada's, lead to increased generic competition and revenue loss.

Differentiation

Gilead's lenacapavir is recognized as the 2024 Breakthrough of the Year for HIV care.

Partnerships with LEO Pharma and Tubulis enhance Gilead's focus on inflammatory and cancer therapies.

Gilead's commitment to health equity initiatives like COMPASS and HepConnect sets it apart.

Upsides

Gilead's strategic partnerships expand its reach in inflammatory and oncology drug markets.

Investment in digital health technologies enhances Gilead's R&D and patient engagement.

Focus on sustainability improves Gilead's operational efficiency and corporate reputation.

Land your dream remote job 3x faster with AI

Try Jobo Free